about
Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function.G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.Blockade of Prostaglandin E2 Receptor 4 Ameliorates Nephrotoxic Serum NephritisImatinib stimulates PGE and attenuates cytokine release via EP4 receptor activationDocking of Meprin α to Heparan Sulphate Protects the Endothelium from Inflammatory Cell ExtravasationButyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival
P50
Q36036213-B2F2E04A-2E99-4BCC-94B8-98AF2A3DBF34Q47850555-4AA7FB14-F618-4420-B1DA-FBE0E6551DF4Q50860077-CFE21DFF-FA15-4C3C-8562-445E51D232ABQ57452652-C5204191-B259-466D-8759-3FBCFF8C224CQ58563652-C47180B0-CAD9-40C7-B10E-FE6384085A00Q64043059-4EC5CDBF-21AC-4BA2-98DA-2C53650A2BA6Q91975562-5CAE2104-C40E-400B-A0AE-E4D3DFCEE046
P50
description
researcher
@en
wetenschapper
@nl
name
Thomas Bärnthaler
@en
Thomas Bärnthaler
@nl
type
label
Thomas Bärnthaler
@en
Thomas Bärnthaler
@nl
prefLabel
Thomas Bärnthaler
@en
Thomas Bärnthaler
@nl
P31
P496
0000-0002-4988-3700